Answers are grounded in this paper and cite their sources.
Short-term cancer-specific survival after RFA remains excellent and most cases are successful based on a combination of imaging and post-ablation biopsies performed almost 2 years after treatment. There were four out of 150 (2.7%) patients who had recurrences with tissue confirmation; one of these patients was detected on imaging and three (2%) were radiologically occult. The absence of enhancement in the setting of non-involuting lesions is not always a guarantee of a successful ablation.
No takes yet. Share an insight, caveat, or question.
Karam et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: